Clinical Trial Update: Exploratory Trial of SAT-003 in Cancer Cachexia Patients With Discontinued Chemotherapy [NA]

View source ↗

Summary

The document reports the completed exploratory trial of SAT-003 in cancer cachexia patients who had discontinued chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia

Drugs mentioned

• SAT-003

Snippet

Sponsor: S-Alpha Therapeutics, Inc. | Conditions: Cancer Cachexia | NA | Status: COMPLETED